...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM

Zenith did not change their year-end date so AGM will probably be about the same date as usual later in the Fall.

Share
New Message
Please login to post a reply